[Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder]

Bull Cancer. 2006 Dec;93(12):1228-32.

[Article in French]

Authors

Patrick Bourguet¹, François Planchamp, Françoise Montravers, Sébastien Vincendeau, Frédéric Courbon, Véronique Edeline, Badia-Ourkia Helal, Dominique Rossi, Arnauld Villers; Standards, Options et Recommandations (SOR); Institut National du Cancer; Fédération nationale des centres de lutte contre le cancer (FNCLCC); Ligue Nationale contre le Cancer; SFMN; Fédération hospitalière de France (FHF); Fédération nationale de cancérologie des CHRU (FNCHRU); Fédération française de cancérologie des CHG (FFCCHG)

Affiliation

¹ Centre Eugène-Marquis, Rennes.

PMID: 17191352

No abstract available

Publication types

Practice Guideline

MeSH terms

Female
France
Humans
Kidney Neoplasms / diagnostic imaging*
Male
Positron-Emission Tomography / methods*
Prostatic Neoplasms / diagnostic imaging*
Radiopharmaceuticals*
Testicular Neoplasms / diagnostic imaging*
Urinary Bladder Neoplasms / diagnostic imaging*

Substances

Radiopharmaceuticals